Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Using microneedles before applying eflornithine cream can make it more effective at stopping hair growth.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata involves immune response and gene changes affecting hair loss.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Rats can develop an immune response to prion protein peptides, but it may cause severe skin issues in older rats.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Fresh plasma transfusions did not help treat Leiner disease in an infant.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.